Janux Therapeutics, Inc.Janux Therapeutics, Inc.Janux Therapeutics, Inc.

Janux Therapeutics, Inc.

No trades
See on Supercharts

Price target

62.780.00 0.00%
The 9 analysts offering 1 year price forecasts for JANX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to JANX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

JANX EPS for the last quarter is −0.30 USD despite the estimation of −0.33 USD. In the next quarter EPS is expected to reach −0.31 USD. Track more of Janux Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Janux Therapeutics, Inc. revenue is expected to reach ‪772.00 K‬ USD. Check out Janux Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, JANX price target is 62.78 USD with a max estimate of 100.00 USD and a min estimate of 25.00 USD. Check if this forecast comes true in a year, meanwhile watch Janux Therapeutics, Inc. stock price chart and keep track of the current situation with JANX news and stock market news.
We've gathered opinions of 10 analysts rating JANX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.